Oxford Drug Design, the Oxford-based AI drug discovery company, has announced an important milestone in the development of ...

The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...

Oxford Drug Design has announced new in vivo results that further validate its emerging first‑in‑class oncology programme, ...

At the heart of every biological process, from the replication of cells to the functioning of the human brain, lies the intricate world of proteins. Understanding the structure of these molecules, ...

This webinar explores how liver microphysiological systems support toxicology from early screening to species-specific risk ...

COLUMBUS, Ohio – Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more efficient. DiffSMol works by analyzing the shapes of known ...

Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in real-world drug discovery Pearl’s performance improved ...

Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to build ...

Seattle biotech startup Rhizome Research has emerged from stealth with technology for creating small-molecule drug candidates.

Cambridge, Massachusetts, January 14, 2025 - Insilico Medicine (“Insilico”, HKEX:03696), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the ...